Project Grant 2146931

Award Date 9/15/22
Completion Date 8/31/23
Dollars Obligated $256K
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Suffern, NY 10901, USA
Similar Awards
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to Lumostech, Inc. under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a smart sleep mask and mobile application to improve sleep for adolescents. The one-year project will apply light flash technology delivered through a sleep mask to advance teenagers' circadian phases without disrupting daytime activities. Cognitive behavioral therapy delivered via mobile...
The federal Project Grant award of $1,120,000.00, awarded by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), supports Northwestern University's research to micromanage human sleep physiology to treat sleep apnea and other disorders. The award, which runs from September 10, 2024 to August 31, 2029, will fund Northwestern's comprehensive research across multiple scientific and technological domains, leveraging the...
The National Science Foundation awarded Jelikalite Corp. a $276,000 Project Grant under the NSF Technology, Innovation, and Partnerships program to develop an EEG-guided transcranial photobiomodulation device for autism treatment. The Small Business Innovation Research Phase I award will support Jelikalite in demonstrating proof of concept for a non-invasive, wearable medical device that stimulates brain tissue with near-infrared radiation. Integrated electroencephalography feedback will monitor...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $399,739 to Attune Neurosciences, Inc. to develop a wearable, head-worn low-intensity focused ultrasound (LIFU) device for enhancing sleep in individuals with substance use disorder (SUD), including opioid use disorder (OUD). The key products and services to be delivered under this Phase I Small Business Innovation Research (SBIR) grant include...
This two-year, $200,000 project grant from the National Science Foundation's Computer and Information Science and Engineering program (CFDA 47.070) will support the development of interpretable deep learning methods and software for automated sleep phenotyping using multimodal health sensing data. Beth Israel Deaconess Medical Center will leverage polyssomnography data and novel radio frequency sensing techniques to build accurate deep learning models for classifying sleep stages and apnea...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $2,537,727 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to The Trustees of the University of Pennsylvania. This 8-year research program, commencing June 1, 2024, aims to investigate the regulation and function of sleep across early development. Key objectives include: Defining the cellular and circuit properties of sleep/wake regulatory neurons throughout...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund the development and validation of a novel wearable sensor system called "SleepTronix" to comprehensively assess sleep, breathing patterns, and circadian rhythms in individuals with obstructive sleep apnea (OSA). The $253,500 award will be used to refine the SleepTronix system, which monitors physiological signals such as EEG,...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Technology Transfer (STTR) Project Grant, awarded to Ai-Neotech LLC in the amount of $275,000 on October 1, 2023, supports the development of a novel consumer product that uses artificial intelligence (AI) and machine learning (ML) models applied to electroencephalogram (EEG) data to predict and mitigate the risk of epileptic seizures for patients and their caregivers. The goal is...
This federal Project Grant award from the National Science Foundation's (NSF) Social, Behavioral, and Economic Sciences (CFDA 47.075) program provides $457,860 to the University of California, Irvine to conduct research on how memory consolidation and processing are affected by multiple nights of sleep. The project aims to systematically examine the contribution of sleep over time to memory formation and retention, using a combination of behavioral, physiological, and computational methods....
This is a Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award, with a total funding amount of $1,566,878.00, is for the "DEVELOPMENT AND VALIDATION OF A NOCTURNAL SLEEP SIGNATURE FOR THE DIAGNOSIS OF IDIOPATHIC HYPERSOMNIA" and runs from June 1, 2024 to May 31, 2027. The award supports research conducted by The...

This National Science Foundation Project Grant of $255,851 awarded on September 15, 2022 will support the development of a neuromodulation device to promote healthy sleep cycles through the completion of prototype engineering. The awardee, Neurolight Inc. of Suffern, New York, will utilize controlled light and sound stimuli delivered via an externally worn system to transpose normal brain wave patterns associated with desired sleep states into recipients suffering from sleep disorders. This aims to provide a safe, non-invasive means of restoring normative sleep without supplements or drugs. The work advances the NSF's Technology, Innovation, and Partnerships program goal of supporting solutions to national challenges through breakthrough technologies. Completion is expected by August 31, 2023.

Generated 1/6/24, 7:41 PM